NCT06828692
Implementation of Machine Learning and Hemodynamic Profiles Based Clinical Decision Support Systems for Personalized Guideline Accordant Antihypertensive Regimens in Primary Care: a Pragmatic Cluster Randomized Controlled Trial
StatusCompleted
PhaseNot applicable
Primary completion
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 4 versions: 4 with changes below. See every version on ClinicalTrials.gov ↗
Notable Eligibility criteria expanded, about 19 words Show 5 more changesShow less
- Trial completed
- Study completion date changed from estimate of May 31, 2026 to Mar 9, 2026
- Enrollment target: estimated 2160 to confirmed 1946
- Secondary endpoints revised (5)
- Site details revised
Notable Trial status: Not Yet Recruiting to Recruitingv3 Show 4 more changesShow less
- Study sites: 0 to 1
- Primary completion date: Dec 31, 2025 to Feb 28, 2026
- Study completion date: Dec 31, 2025 to May 31, 2026
- Start date changed from estimate of May 19, 2025 to May 26, 2025
- Notable Start date: Feb 28, 2025 to May 19, 2025
- Eligibility criteria expanded, about 14 words
- Secondary endpoints: 6 to 5
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
hierarchical composite outcome
Timeframe: Baseline; 12 weeks.
Secondary (5)
Individual component of the three-tier hierarchical composite primary outcome at 12 weeks.
Changes in office systolic and diastolic BP from baseline to 4 weeks and 12 weeks.
Average 24-hour ambulatory systolic and diastolic blood pressure, along with blood pressure control rate at 12 weeks.
Changes in hemodynamic parameters from baseline to 12 weeks measured by ICG.
Differences in the three-tier hierarchical composite primary outcome and each component between the two intervention groups at 12 weeks.
Arms and interventions
Group A (CG+ML)Experimental
Group B (CG+ICG+ML)Experimental
Group C (UC)Other
Combination products: Group A (clinical guideline+machine learning), Group B (clinical guideline+impedance cardiograph+machine learning)
Other: Group C (usual care)
Sites
1 site in 1 country
- Fuwai Shenzhen Hospital, Chinese Academy of Medical SciencesShenzhen, Shenzhen, China